Skip to main content
. 2017 Sep 1;12(9):e0182397. doi: 10.1371/journal.pone.0182397

Fig 3. Comparison of overall survival (OS) rates and disease-specific survival (DSS) ratesof infiltrating ductal carcinoma (IDC) and infiltrating lobular carcinoma (ILC) based on hormone receptor status.

Fig 3